Oncore Pharma

As an early pioneer in liquid biopsy, a partner of Oncore Pharma developed one of the earliest blood-based biomarker tests for the early detection of colorectal cancer, ColonSentry®. To date, more than 100,000 American patients have benefited from the ColonSentry test.